regular insulin

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

Type 1 DiabetesEffectivenessSpinal Cord InjuryGrowth Hormone Deficiency

77 competitors in Type 1 Diabetes

#DrugCompanyPhaseTrials

1

Aldactone

Pfizer

Approved

22

Rituxan

Roche

Approved

23

Invokana

WWim Janssens

Approved

14

Ozempic

Novo Nordisk

Phase 3

75

Singulair

OOrganon and Co

Approved

—6

Stelara

Johnson & Johnson

Phase 3

17

Inpefa

LLexicon Pharmaceuticals

Phase 3

58

Tricor

JJagotec

Phase 3

29

Atorvastatin Calcium

Merck & Co.

Phase 3

110

Diamox

Teva

Phase 2

2Show 25 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

14 more indications

Cirrhosis1 trial

Various Insulin Regimens for Diabetic Inpatients With Cirrhosis Trial

Unknown status·—·Phase 4·NCT01143948·45 enrolled

Stem Cell Transplant1 trial

Glucose Control In Hematopoetic Stem Cell Transplant

Terminated·UUniversity of Oklahoma·N/A·NCT00582036·11 enrolled

Parenteral Nutrition1 trial

Glargine Insulin vs.Continuous Regular Insulin in Diabetic Surgical Patients Receiving Parenteral Nutrition (GLUCOSE-in-PN)

Completed·KKing Faisal Specialist Hospital & Research Center·Phase 4·NCT02216799·61 enrolled

Acute Coronary Syndrome1 trial

Feasible Insulin Algorithm for Glycemic Control in Patients With Acute Coronary Syndrome

Suspended·—·Phase 4·NCT01151176·130 enrolled

Stroke1 trial

Insulin Glargine Versus Regular Insulin Based Regimens in Glycemic Control After Acute Stroke

Unknown status·NNational Taiwan University Hospital·Phase 3·NCT02607943·120 enrolled

Effectiveness1 trial

Effectiveness of Subcutaneous Glargine On The Time To Closure of The Anion Gap in Patients Presenting to the Emergency Department With Diabetic Keto-acidosis

Completed·TThe University of Texas Health Science Center, Houston·N/A·NCT02006342·40 enrolled

After Cardiac Surgery1 trial

The Effect of Intranasal Insulin Administration on Cognitive Function After Cardiac Surgery.

Unknown status·MMcGill University Health Centre/Research Institute of the McGill University Health Centre·N/A·NCT03324867·316 enrolled

Type 2 Diabetes Mellitus1 trial

Evaluation of the Safety and Efficacy of Insulin Glargine + Glulisine or Insulin Regular + NPH Insulin (Isophane Insulin) Use in Type 2 Diabetes Mellitus Patients With Moderate Renal Failure.

Completed·Sanofi·Phase 4·NCT01122979·72 enrolled

Growth Hormone Deficiency1 trial

Pegvisomant With Glucagon Test to Assess for Adult Growth Hormone Deficiency

Unknown status·OOregon Health and Science University·N/A·NCT01804413·10 enrolled

Type 2 Diabetes1 trial

Basal Bolus Insulin Versus SSRI in Type 2 Diabetes Undergoing General Surgery

Completed·EEmory University·Phase 4·NCT00596687·234 enrolled

ESS1 trial

SNIFF 120: Study of Nasal Insulin to Fight Forgetfulness (120 Days)

Completed·UUniversity of Washington·Phase 2·NCT00438568·173 enrolled

Randomized1 trial

Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D

Completed·XXeris Pharmaceuticals·Phase 2·NCT04074317·18 enrolled

Spinal Cord Injury1 trial

Safety and Feasibility of Intranasal Insulin in Patients With Spinal Cord Injury

Recruiting·HHealthPartners Institute·Phase 1·NCT07384052·12 enrolled

Unspecified2 trials

Lyspro Insulin vs Regular Insulin in Cirrhotic Patients

Completed·UUniversity of Campania Luigi Vanvitelli·Phase 4·NCT00513201

Feasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Glucose Levels After Eating

Completed·BBecton, Dickinson and Company·Phase 2·NCT00553488·30 enrolled

Details

Drug Info

Related News